- Home
- BVS vs BME Comparison
BVS vs BME Comparison
Compare BVS & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BVS | BME |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.1M | 547.5M |
| IPO Year | 2016 | 2005 |
Fundamental Metrics
Financial Performance| Metric | BVS | BME |
|---|---|---|
| Price | $10.49 | $40.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 440.5K | 49.0K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $7.06 | N/A |
| P/E Ratio | $32.03 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $35.03 |
| 52 Week High | $10.58 | $42.74 |
Technical Indicators
Market Signals| Indicator | BVS | BME |
|---|---|---|
| Relative Strength Index (RSI) | 72.59 | 53.01 |
| Support Level | $8.43 | $37.71 |
| Resistance Level | N/A | $42.34 |
| Average True Range (ATR) | 0.36 | 0.89 |
| MACD | 0.14 | 0.26 |
| Stochastic Oscillator | 91.23 | 82.10 |
Price Performance
Historical ComparisonAbout BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.